AHRQ responds to letter from Prostate Cancer Roundtable

Members of the Prostate Cancer Roundtable have received a letter from the Agency for Healthcare Research and Quality (AHRQ) addressing issues raised by the Roundtable members about the draft USPSTF recommendations on use of the PSA test in screening for risk of prostate cancer. … READ MORE …

The walnuts are back in vogue (at least with mice)

According to a media release we received yesterday, a new paper in the British Journal of Nutrition suggests that “walnuts may help to prevent prostate cancer risk.” … READ MORE …

Sebelius has NOT overruled USPSTF recommendation after all

For our US-based readers … It appears that Rep. Kucinich’s statements on his web site (reported on this web site a few days ago) are something of a political simplification of reality. … READ MORE …

The value of MRI prior to surgery as a treatment for localized prostate cancer

A recent media release from the Radiological Society of North America (RSNA) is headed, “Preoperative MRU may reduce risk of nerve damage in prostate cancer surgeries” … and this is absolutely true. … READ MORE …

Dutasteride as a single agent for low-risk prostate cancer

According to data just reported in The Lancet, some men with low-volume, low-risk prostate cancer may be able to delay progression of their disease if treated only with the 5α-reductase inhibitor dutasteride (Avodart®). … READ MORE …

Tasquinimod + cabazitaxel in heavily pre-treated men with mCRPC

According to media information from Active Biotech this morning, the company has initiated an early stage, combination therapy trial (the so-called CATCH trial) of their investigational agent tasquinimod + cabazitaxel (Jevtana®) for the treatment of men with heavily pre-treated, metastatic, castration-resistant prostate cancer (mCRPC). … READ MORE …

Has Sebelius overruled USPSTF recommendation on PSA screening?

According to an announcement on the web site of Congressmen Dennis Kucinich late yesterday, HHS Secretary Kathleen Sebelius has agreed to overule the draft recommendation issued by the U.S. Preventive Services Task Force (USPSTF) related to the use of PSA testing as a means to detect prostate cancer. … READ MORE …

New Jersey passes legislation against USPSTF recommendation on prostate cancer screening

According to a media release issued late yesterday by the American Urological Association, Governor Christie has signed legislation in New Jersey that asks “the Congress of the United States to seek the withdrawal of the United States Preventative Services Task Force recommendation against prostate-specific antigen-based screening for prostate cancer for men in all age groups.” … READ MORE …

Sequencing of treatment with new therapeutic agents for advanced prostate cancer

The January 2012 issue of Oncology contains an open access, full-text article on the future sequencing of the recently approved and potentially new drugs that are or should soon be available for the treatment of advanced prostate cancer. … READ MORE …

The future of focal therapy

Two “pro” and “con” commentaries appeared on line this week in the Journal of Urology under the heading “Focal therapy will become standard treatment for localized prostate cancer.” .. READ MORE …

An update on views about the USPSTF recommendation and prostate cancer screening

Apparently, earlier this week, Congressmen Runyan and Baca (the co-chairmen of the Congressional Prostate Cancer Task Force) sent a letter to Secretary Sebelius about prostate cancer screening. … READ MORE …

Will active surveillance save us money in management of prostate cancer?

From a health economics point of view, prostate cancer costs a lot of money every year — because a lot of men get diagnosed and treated. … READ MORE …

Trip’s trip … 10 years of battling metastatic prostate cancer

In 2001, when he was just 49 years old, Ward “Trip” Casscells experienced lower back pain that became progressively worse. Then, he felt a lump in his abdominal area. He had an aggressive, metastatic prostate cancer. … READ MORE …

Self-referral and the role of IMRT in treatment of prostate cancer

The issue of whether some urology practices are investing in equipment capable of delivering intensity-modulated radiation therapy (IMRT) with financial motives is back on the front burner again. … READ MORE …

“Peripheral” androgen deprivation for men with a rising PSA after surgery and/or radiation therapy

What is the best type of treatment to offer a man after primary and (perhaps) appropriate secondary forms of treatment leave him with a rising PSA? … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 249 other followers